Advertising in Drug Reference and Clinical Apps: What Buyers Should Know

Drug reference and clinical decision apps are part of many HCPs' daily routine. For pharma, they combine two useful features: a verified professional audience and a clinical context. They are often classed as endemic and point-of-care media.

What these apps offer

Rules for each format come from the app and from your review process. Some placements near clinical content have restrictions on what can appear.

Why they can target precisely

Users register with name, specialty, and often NPI. Apps match these to reference data. This allows:

• Targeting by your NPI list.
• Reporting delivery by NPI.
• Joining exposure data with your measurement partner.

Ask what share of active users are verified, and how often verification is refreshed.

Checking coverage

Before discussing price, match your target list:

• How many of my target NPIs are active users in the last 30 or 90 days?
• What is coverage by tier and specialty?
• How often do they use the app?

An app may have a large total audience but cover a small share of a specialist list.

Evaluating lift claims

Many clinical app vendors share case studies showing prescription lift. Read them carefully:

• Was there a control group, and how was it matched?
• Were exposed HCPs heavier app users, who may differ from non-users?
• What time window was used?
• Was the study designed before the campaign?

The ROI of EHR advertising article covers the same questions in detail. Vendor studies are useful, but ask to replicate the design with your own measurement partner.

How apps fit the plan

Clinical apps usually sit between broad HCP programmatic and high-touch channels:

• More context and verification than open-web programmatic.
• Less depth than email or field.
• Often useful for HCPs reps cannot reach.

Coordinate frequency with programmatic, since many app users also see your open-web ads.

Questions to ask

1. How are users verified, and what share are verified HCPs?
2. Match my target list: coverage by tier and active use.
3. Which formats are available near clinical content, and what rules apply?
4. What NPI-level reporting can you share?
5. How were your lift studies designed?

Common mistakes

• Buying based on total users rather than target-list coverage.
• Taking case study lift figures at face value.
• No frequency coordination with programmatic.
• Repurposing display creative without considering the clinical context.

Practical takeaway

Ask each clinical app for active-user coverage of your top-tier NPIs in the last 90 days. Rank options by that number before comparing price or formats.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.